Savient (SVNT) Shares Sink Midday as Leerink Cuts to Underperform
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Price: $40.05 --0%
Rating Summary:
2 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
2 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Shares of Savient Pharmaceuticals (NASDAQ: SVNT) have taken another leg lower in afternoon trade as Leerink Swann, a pharma-focused research firm, downgraded the stock from Market Perform to Underperform.
The lowered investment rating follows Q1 results and news the company submitted its MAA for KRYSTEXXA to the EMA this morning.
Savient shares were trading down nearly 15 percent prior to the downgrade; shares are now down nearly 20 percent from Wednesday's closing price. The stock last traded at $8.86.
For more ratings news on Savient Pharmaceuticals click here and for the rating history of Savient Pharmaceuticals click here.
The lowered investment rating follows Q1 results and news the company submitted its MAA for KRYSTEXXA to the EMA this morning.
Savient shares were trading down nearly 15 percent prior to the downgrade; shares are now down nearly 20 percent from Wednesday's closing price. The stock last traded at $8.86.
For more ratings news on Savient Pharmaceuticals click here and for the rating history of Savient Pharmaceuticals click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Nutanix (NTNX) PT Raised to $80 at Oppenheimer Into EPS
- Citi cuts Weibo stock rating to Neutral, lowers price target
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
